Case Control Study
Copyright ©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 418-428
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.418
Figure 3
Figure 3 Comparison of 3 indexs between the liver fibrosis and non-fibrosis groups. A: Angiopoietin-like protein 8; B: Triglyceride-glucose index levels; C: C-reactive protein. MAFLD: Metabolic dysfunction-associated fatty liver disease; ANGPTL8: Angiopoietin-like protein 8; CRP: C-reactive protein.